Citigroup Inc Vericel Corp Transaction History
Citigroup Inc
- $190 Billion
- Q1 2025
A detailed history of Citigroup Inc transactions in Vericel Corp stock. As of the latest transaction made, Citigroup Inc holds 110,116 shares of VCEL stock, worth $4.69 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
110,116
Previous 90,057
22.27%
Holding current value
$4.69 Million
Previous $4.95 Million
0.65%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding VCEL
# of Institutions
291Shares Held
52.1MCall Options Held
36.7KPut Options Held
6.4K-
Black Rock Inc. New York, NY8.06MShares$343 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$149 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.88MShares$123 Million3.98% of portfolio
-
State Street Corp Boston, MA2.44MShares$104 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.27MShares$96.7 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.01B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...